The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABLYNX NV | SPONSORED ADR | 00372Y905 | 10,495 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| ACCELERON PHARMA INC | COM | 00434H108 | 4,307 | 101,500 | SH | SOLE | 101,500 | 0 | 0 | ||
| ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 1,267 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS | COM | 00847X104 | 7,432 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONSORED ADR | 023111206 | 3,448 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
| ARDELYX | COM | 039697107 | 5,940 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| ARGENX | SPONSORED ADR | 04016X101 | 5,587 | 88,500 | SH | SOLE | 88,500 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 6,652 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 55,751 | 1,970,000 | SH | SOLE | 1,970,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 272 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES | COM | 09627Y109 | 55,426 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 2,778 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 14,200 | 1,700,600 | SH | SOLE | 1,700,600 | 0 | 0 | ||
| CORIUM INTERNATIONAL INC | COM | 21887L107 | 10,186 | 1,060,000 | SH | SOLE | 1,060,000 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 6,597 | 281,000 | SH | SOLE | 281,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 6,118 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 2,781 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 8,486 | 846,900 | SH | SOLE | 846,900 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 17,064 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 5,769 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 14,524 | 898,800 | SH | SOLE | 898,800 | 0 | 0 | ||
| INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 4,703 | 1,802,000 | SH | SOLE | 1,802,000 | 0 | 0 | ||
| LOXO ONCOLOGY | COM | 548862101 | 14,841 | 176,300 | SH | SOLE | 176,300 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 4,777 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 1,206 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
| QUANTERIX CORP | COM | 74766Q101 | 1,395 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 1,113 | 38,300 | SH | SOLE | 38,300 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 9,512 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
| SPECTRUM PHARMACEUTICALS INC | COM | 84763A108 | 587 | 31,000 | SH | SOLE | 31,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 9,062 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 720 | 74,074 | SH | SOLE | 74,074 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICALS INC | COM | 90400D108 | 4,174 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 1,778 | 90,801 | SH | SOLE | 90,801 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 1,951 | 480,558 | SH | SOLE | 480,558 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 11,399 | 320,200 | SH | SOLE | 320,200 | 0 | 0 | ||